State Street Health Care Select Sector SPDR ETF (XLV) Dividend Yield, History & Forecast

State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.54% ($2.53 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 24, 2026. market capitalization is approximately $41.79B.

XLV fund composition

XLV holds 60 positions, with 60.3% of assets in its ten largest. It charges an expense ratio of 0.08%, and manages $41.87B.

Top 10 holdings

HoldingWeight
LLYELI LILLY + CO15.14%
JNJJOHNSON + JOHNSON10.45%
ABBVABBVIE INC7.39%
UNHUNITEDHEALTH GROUP INC6.44%
MRKMERCK + CO. INC.5.39%
TMOTHERMO FISHER SCIENTIFIC INC3.64%
AMGNAMGEN INC3.49%
ABTABBOTT LABORATORIES3.18%
GILDGILEAD SCIENCES INC2.78%
PFEPFIZER INC2.43%

Sector allocation

Healthcare99.4%Technology0.5%Cash & Others0.1%

Frequently Asked Questions about State Street Health Care Select Sector SPDR ETF (XLV)

What is State Street Health Care Select Sector SPDR ETF's dividend yield?
State Street Health Care Select Sector SPDR ETF (XLV) pays a current trailing twelve-month dividend yield of 1.54%, which works out to $2.53 per share annually based on the most recent payout schedule.
When does State Street Health Care Select Sector SPDR ETF pay distributions?
The most recent ex-dividend date was June 22, 2026. The next scheduled dividend payment date is June 24, 2026.
How many years has State Street Health Care Select Sector SPDR ETF increased its dividend?
State Street Health Care Select Sector SPDR ETF (XLV) has increased its dividend for 5 consecutive years.
What does State Street Health Care Select Sector SPDR ETF invest in?
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more...